Screening for MASLD is Cost-Effective for PatientsEmerging research continues to shape our understanding of liver health, from cost-effective screening for high-risk MASLD patients to alarming rates...
Terri’s StoryWhen my doctor told me that I had fatty liver disease in 2015, the communication was that it was no big deal. In 2016, I was diagnosed with lupus then pancreatitis. Eventually, the...
Why Hepatitis C Treatment Matters: Improving Patient Outcomes Beyond Liver HealthHepatitis C continues to be a significant public health concern with effects that reach beyond liver function. As a...
Congress goes into recess in October while staff work behind the scenes to prepare for a potentially busy November lame-duck session Congress is in recess with Representatives and Senators back in...
Cancer Care for the Underrepresented #Octoberis4Livers Welcome back to Liver Cancer News! As we mark Liver Cancer Awareness Month in October, we’re emphasizing the critical role of education and...
Emerging Evidence in Liver Health: GLP-1, Pollution, and MoreDespite awareness efforts, fatty liver disease remains largely overlooked in major global health strategies. Recent studies show...
New changes in 2025 ICD-10 Coding includes a code for cholestatic pruritus Critical Path Global Impact Conference highlights collaborative progress The Critical Path Global...
As Deadly Liver Cancer Rises, Collaborative, Targeted Prevention and Surveillance Necessary Global Liver Institute’s #OctoberIs4Livers Campaign Sheds Light on Unique Challenges and Solutions in...
Congress reconvenes in September for its last push to legislate before the November elections Congress is entering a very busy work period in September, the last before the November elections. GLI...
Millennials and Generation X Face Higher Risk of Liver Cancer Than Previous Generations Thank you for being a part of Liver Cancer News! As we gear up for Liver Cancer Awareness Month next month, we...
Recent News
Rural Communities at Risk: Global Liver Institute Champions Awareness for Rare Liver Diseases(Washington, DC, February 1, 2025) – As rural healthcare access shrinks across the United States and remains limited worldwide, Global Liver Institute (GLI) is shining a...
Global Liver Institute Supports CMS Coverage of Obesity Medications(Washington, D.C., January 22, 2025) – Global Liver Institute (GLI) was very pleased to see the U.S. Centers for Medicare and Medicaid Services (CMS) take the step towards expanding coverage for...
Breaking: Global Liver Institute Statement on U.S. End-of-Year Health Package(Washington, D.C., December 17, 2024) – Global Liver Institute (GLI) celebrates the release of bill text last night for a continuing resolution (CR) for FY2025 from the U.S. House of...
The Case for Universal Access to Hepatitis C DAA Treatment for Your PatientsHepatitis C is a viral infection of the liver caused by the hepatitis C virus (HCV) and spread through blood-to-blood exposure. The majority of people exposed to HCV develop chronic infection,...
Can Blood Tests Help Predict Liver Transplant Outcomes? As we conclude this year, the Pediatric and Rare Liver Diseases team is reflecting on the incredible progress made by our council and patient organizations in 2024. We were so proud to see so...
